Clinical Trial Update: Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adjuvant immunotherapy in combination with chemoradiation for high-risk resectable biliary tract cancers, including extrahep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Extrahepatic Cholangiocarcinoma
• Gallbladder Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Biliary Tract Cancer, Extrahepatic Cholangiocarcinoma | Phase 2 | Status: UNKNOWN